Product Recalls in Massachusetts

Product recalls affecting Massachusetts — including food, drugs, consumer products, medical devices, and vehicles distributed to Massachusetts. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,765 recalls have been distributed to Massachusetts in the last 12 months.

52,647 total recalls
2,765 in last 12 months

Showing 801820 of 13,418 recalls

DrugNovember 25, 2024· Macleods Pharmaceuticals Ltd

Recalled Item: Olanzapine Tablets Recalled by Macleods Pharmaceuticals Ltd Due to Failed...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 22, 2024· Jubilant Draximage Inc., dba Jubilant Radiopharma

Recalled Item: Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection...

The Issue: Failed Stability Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 22, 2024· Provepharm Inc.

Recalled Item: Dihydroergotamine Mesylate Injection Recalled by Provepharm Inc. Due to...

The Issue: Discoloration

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 22, 2024· Apothecus Pharmaceutical Corp.

Recalled Item: VCF Recalled by Apothecus Pharmaceutical Corp. Due to CGMP deviations: out...

The Issue: CGMP deviations: out of specifications for assay

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 22, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Javygtor (sapropterin dihydrochloride) Tablets 100mg Recalled by Dr. Reddy's...

The Issue: Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine DR Capsules USP 60 mg Recalled by Rising Pharma Holding, Inc. Due...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Rising Pharma Holding,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Rising Pharma Holding,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablet Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund